These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 38255650)

  • 21. Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED-J Study.
    Wada H; Shinozaki T; Suzuki M; Sakagami S; Ajiro Y; Funada J; Matsuda M; Shimizu M; Takenaka T; Morita Y; Yonezawa K; Matsubara H; Ono Y; Nakamura T; Fujimoto K; Ninomiya A; Kato T; Unoki T; Takagi D; Wada K; Wada M; Iguchi M; Yamakage H; Kusakabe T; Yasoda A; Shimatsu A; Kotani K; Satoh-Asahara N; Abe M; Akao M; Hasegawa K;
    J Am Heart Assoc; 2022 Feb; 11(3):e023464. PubMed ID: 35048713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biomarkers in the diagnosis of cardiovascular emergencies : Acute coronary syndrome and differential diagnoses].
    Möckel M
    Internist (Berl); 2019 Jun; 60(6):564-570. PubMed ID: 31062038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
    Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
    J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics.
    Chung EYM; Trinh K; Li J; Hahn SH; Endre ZH; Rogers NM; Alexander SI
    Front Cardiovasc Med; 2022; 9():868658. PubMed ID: 35669475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute Kidney Injury, Type - 3 cardiorenal syndrome, Biomarkers, Renal Replacement Therapy].
    Di Lullo L; Bellasi A; Barbera V; Cozzolino M; Russo D; De Pascalis A; Santoboni F; Villani A; De Rosa S; Colafelice M; Russo L; Ronco C
    G Ital Nefrol; 2016; 33(3):. PubMed ID: 27374388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volume overload and cardiorenal syndromes.
    Ronco C; Maisel A
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():Si-iv; quiz Svi. PubMed ID: 20653717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic biomarkers in acute coronary syndrome.
    Salvagno GL; Pavan C
    Ann Transl Med; 2016 Jul; 4(13):258. PubMed ID: 27500159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration.
    Milovanova LY; Dobrosmyslov IA; Milovanov YS; Taranova MV; Kozlov VV; Milovanova SY; Kozevnikova EI
    Ter Arkh; 2018 Jun; 90(6):48-54. PubMed ID: 30701904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The acute kidney injury to chronic kidney disease transition in a mouse model of acute cardiorenal syndrome emphasizes the role of inflammation.
    Matsushita K; Saritas T; Eiwaz MB; McClellan N; Coe I; Zhu W; Ferdaus MZ; Sakai LY; McCormick JA; Hutchens MP
    Kidney Int; 2020 Jan; 97(1):95-105. PubMed ID: 31623859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [PATHOPHYSIOLOGY OF THE CARDIORENAL SYNDROME].
    Balint I; Vučak J; Bašić-Marković N; Klarić D; Šakić VA
    Acta Med Croatica; 2016 Dec; 70(4-5):325-31. PubMed ID: 29087629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
    Wallentin L; Eriksson N; Olszowka M; Grammer TB; Hagström E; Held C; Kleber ME; Koenig W; März W; Stewart RAH; White HD; Åberg M; Siegbahn A
    PLoS Med; 2021 Jan; 18(1):e1003513. PubMed ID: 33439866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biomarkers of cardiorenal syndrome].
    Kuster N; Moréna M; Bargnoux AS; Leray H; Chenine L; Dupuy AM; Canaud B; Cristol JP
    Ann Biol Clin (Paris); 2013; 71(4):409-18. PubMed ID: 23906568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk.
    Buliga-Finis ON; Ouatu A; Badescu MC; Dima N; Tanase DM; Richter P; Rezus C
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel biomarkers for cardiovascular risk prediction.
    Wang J; Tan GJ; Han LN; Bai YY; He M; Liu HB
    J Geriatr Cardiol; 2017 Feb; 14(2):135-150. PubMed ID: 28491088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome.
    Katsioupa M; Kourampi I; Oikonomou E; Tsigkou V; Theofilis P; Charalambous G; Marinos G; Gialamas I; Zisimos K; Anastasiou A; Katsianos E; Kalogeras K; Katsarou O; Vavuranakis M; Siasos G; Tousoulis D
    Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Cardiac Troponins in Predicting Adverse Outcomes in Acute Coronary Syndrome With Renal Dysfunction.
    Noorayingarath H; Panjiyar BK; Gela I; Ramalingam L
    Cureus; 2023 Oct; 15(10):e47104. PubMed ID: 38022315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease.
    Bjurman C; Petzold M; Venge P; Farbemo J; Fu ML; Hammarsten O
    Clin Biochem; 2015 Mar; 48(4-5):302-7. PubMed ID: 25637776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac biomarkers in dialysis.
    Mahmood U; Johnson DW; Fahim MA
    AIMS Genet; 2017; 4(1):1-20. PubMed ID: 31435501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.